Baillie Gifford - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 396 filers reported holding SEATTLE GENETICS INC in Q3 2020. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q2 2020$574,772,000
+16.4%
3,382,609
-21.0%
0.44%
-18.1%
Q1 2020$493,919,000
+1.6%
4,280,810
+0.6%
0.54%
+13.8%
Q4 2019$486,362,000
-13.2%
4,256,629
-35.1%
0.47%
-26.2%
Q3 2019$560,331,000
+21.2%
6,561,252
-1.8%
0.64%
+30.0%
Q2 2019$462,307,000
-5.6%
6,679,766
-0.1%
0.49%
-8.4%
Q1 2019$489,488,000
+28.5%
6,683,336
-0.6%
0.54%
+8.1%
Q4 2018$380,855,000
-63.4%
6,721,760
-50.2%
0.50%
-55.9%
Q3 2018$1,039,997,000
+10.2%
13,485,446
-5.2%
1.12%
+10.2%
Q2 2018$944,051,000
+22.9%
14,219,765
-3.1%
1.02%
+13.1%
Q1 2018$767,959,000
-4.1%
14,672,519
-2.0%
0.90%
-9.4%
Q4 2017$800,601,000
-4.5%
14,964,511
-2.9%
1.00%
-6.3%
Q3 2017$838,523,000
+2.3%
15,411,197
-2.7%
1.06%
-3.6%
Q2 2017$819,526,000
-19.5%
15,839,321
-2.2%
1.10%
-25.6%
Q1 2017$1,018,115,000
+16.4%
16,196,553
-2.3%
1.48%
+3.0%
Q4 2016$874,433,000
-3.6%
16,570,644
-1.3%
1.44%
+1.3%
Q3 2016$907,142,000
+31.2%
16,795,793
-1.9%
1.42%
+15.0%
Q2 2016$691,663,000
+14.1%
17,116,142
-0.9%
1.23%
+15.8%
Q1 2016$606,029,000
-21.3%
17,270,681
+0.7%
1.07%
-20.4%
Q4 2015$769,818,000
+16.8%
17,152,807
+0.2%
1.34%
+3.8%
Q3 2015$659,051,000
-10.2%
17,111,091
+12.9%
1.29%
-2.2%
Q2 2015$733,806,000
+36.1%
15,161,292
-0.6%
1.32%
+29.3%
Q1 2015$539,213,000
+10.1%
15,253,520
+0.1%
1.02%
+4.0%
Q4 2014$489,617,000
-10.4%
15,238,601
+3.6%
0.98%
-18.1%
Q3 2014$546,684,000
+9.3%
14,703,706
+12.4%
1.20%
+10.8%
Q2 2014$500,187,000
-14.6%
13,076,781
+1.7%
1.08%
-21.7%
Q1 2014$585,956,000
+10.3%
12,861,181
-3.4%
1.38%
+10.0%
Q4 2013$531,167,000
+23.5%
13,315,804
+35.7%
1.26%
+15.3%
Q3 2013$430,030,000
+160.9%
9,811,312
+87.3%
1.09%
+117.6%
Q2 2013$164,802,0005,238,4400.50%
Other shareholders
SEATTLE GENETICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
CIBC WORLD MARKETS CORP 21,595$4,581,3790.04%
NORTH STAR ASSET MANAGEMENT INC 3,310$702,2160.04%
AlphaMark Advisors, LLC 14$30.00%
View complete list of SEATTLE GENETICS INC shareholders